What is API Holdings (Pharmeasy) Unlisted Share Price?

Overview of API Holdings (Pharmeasy) Unlisted Share Price:

Since 2012, entrepreneurs in the digital healthcare industry have been making significant strides, with API Holdings emerging as India's largest digital healthcare platform based on the Gross Merchandise Value (GMV) of products and services sold for the year ended March 31, 2021. The unlisted shares of API Holdings have garnered attention as the company operates an integrated, end-to-end business model, effectively addressing consumers' diverse healthcare needs. Headquartered in Ghatkopar West, Mumbai, API Holdings has positioned itself at the forefront of the digital healthcare landscape by offering comprehensive services to consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors and clinics, as well as diagnostic labs. The company's commitment to building solutions across the healthcare ecosystem underscores its pivotal role in driving innovation and accessibility within the industry.

Products and Services by API Holdings (Pharmeasy) :

API Holdings unlisted shares power an online platform providing diverse health services to customers. This innovative approach reinforces the company's commitment to accessible and efficient healthcare delivery, catering to a broad spectrum of user needs in the digital age.

Financial Background of API Holdings (Pharmeasy) Unlisted Share:

The Revenue from Operations (RFO) for the company, denominated in INR Crores, depicts a notable upward trajectory over the past few years. In 2020, the RFO stood at 28.45 Crores, marking the starting point of this growth trend. Subsequently, there was a substantial leap to 2335.27 Crores in 2021, followed by a remarkable increase to 5728.82 Crores in 2022. The positive momentum continued with a further boost to 6643.94 Crores in 2023. This consistent and substantial growth in RFO illustrates the company's effective business strategies and increasing market presence, positioning it as a notable player in its industry.

API Holdings (Pharmeasy) Unlisted Shares and Corporate Actions: 

In 2023, API Holdings executed key moves, acquiring Thyrocare through a share purchase agreement with its subsidiary, Docon Technologies. The acquisition involved purchasing 3,49,72,999 equity shares for Rs 45,464.90 and 2,683,093 shares for Rs 3,488.02 through an open offer. Simultaneously, API implemented a Corporate Convertible Preference Shares (CCPS) swap with a ratio of 1:56, issuing 68,42,983 preference shares to Medlife International as part of a Scheme of Amalgamation. These strategic actions highlight API's commitment to growth and consolidation in the healthcare sector.

API Holdings (Pharmeasy) Unlisted Share Price:

The current  API Holdings (Pharmeasy) Unlisted share price as of 1 February is ₹ 9.60 per share. 

 API Holdings (Pharmeasy) Unlisted Share Price in Depth 

Face Value of  API Holdings (Pharmeasy) Unlisted Share:₹ 1.00

Price per share as of 1 February:₹ 9.60

You can check the API Holdings (Pharmeasy) Unlisted Share Current Price at  Precize.in  

Price history of API Holdings (Pharmeasy) Unlisted Shares:

API Holdings (Pharmeasy) Unlisted Shares and its Shareholding Pattern:

The shareholding pattern indicates a diverse ownership structure, with notable stakes held by entities such as Naspers Ventures B. V (13.24%), MacRitchie Investments Pte. Ltd (11.93%), and TPG Growth V SF Markets Pte. Ltd (7.32%). Evermed Holdings Pte. Ltd. holds 6.45%, while Prasid Uno Family Trust, through trustee Surbhi Singh, owns 6.10%. The remaining 54.96% is distributed among other stakeholders, reflecting a balanced and varied investor base.

Financials of API Holdings (Pharmeasy) Unlisted Shares. 

Balance Sheet of API Holdings (Pharmeasy) Unlisted Shares:

Income Statement of API Holdings (Pharmeasy) Unlisted Shares:

 

Growth Opportunities and Challenges for API Holdings (Pharmeasy)Unlisted Shares.

Opportunities for API Holdings (Pharmeasy) Unlisted Shares:

The company can leverage its customer base and brand equity to expand into new markets, offering services like telemedicine consultations and online health check-ups. Adopting innovative technologies, particularly artificial intelligence, can further enhance the overall customer experience, streamlining processes and ensuring efficiency in its healthcare services. This strategic approach aligns with the company's potential for sustained growth and innovation in the dynamic healthcare sector.

Challenges for API Holdings (Pharmeasy) Unlisted Shares:

The Indian e-pharmacy market is highly competitive and fragmented, posing challenges such as legal disputes over product quality or delivery delays. Operational risks, including supply chain disruptions and inventory shortages, further add complexity. Navigating these challenges requires a strategic approach focused on quality control and operational resilience within the dynamic e-pharmacy landscape in India.